前往化源商城
入驻化源商城

品牌现货直购
供应商:我要出现这里







查看所有供应商和价格请点击:

17605-67-3生产厂家

17605-67-3价格

17605-67-3

17605-67-3结构式
17605-67-3结构式
  • 常用中文名:岩藻甾醇
  • 常用英文名:Fucosterol
  • CAS号:17605-67-3
  • 分子式:C29H48O
  • 分子量:412.69100
  • 相关类别: 生物化工 植物提取物
  • 发布时间:2018-08-03 12:13:18
  • 更新时间:2024-01-10 12:48:29
  • Fucosterol 是从 E. stolonifera 中分离出来的,具有抗脂肪形成,抗糖尿病和抗癌活性。 Fucosterol 通过调节 PPARα 和 C/EBPα 的表达来调节脂肪形成。

化源商城直购

中文名 岩皂甾醇
英文名 fucosterol
中文别名 墨角藻甾醇
岩藻甾醇
英文别名 trans-24-Ethylidenecholesterol
D5-avenasterol
MFCD00037543
FUCOSTEROL
Fucosterin
trans-Stigmasta-5,24(28)-dien-3b-ol
24-ETHYLIDENCHOLEST-5-ENE-3B-OL
描述 Fucosterol 是从 E. stolonifera 中分离出来的,具有抗脂肪形成,抗糖尿病和抗癌活性。 Fucosterol 通过调节 PPARα 和 C/EBPα 的表达来调节脂肪形成。
相关类别
靶点

PPARα; C/EBPα[1]

体外研究 与完全分化的对照脂肪细胞相比,岩藻糖醇(0-50μM;7天)抑制PPARα和C/EBPα的表达[1]。岩藻糖醇对T47D和HT29细胞系具有细胞毒性,IC50值分别为27.94和70.41μg/ml,分别[3]。岩藻糖醇降低细胞HEK293,MCF-7和SiHa细胞增殖,IC50值分别为185.4,43.3和34.0μg/ml[4]。细胞活力测定[1]细胞系:3T3-L1脂肪细胞浓度:0μM;25μM;50μM孵育时间:7天结果:抑制PPARα和C/EBPα表达。
体内研究 岩藻糖醇(口服给药;30mg/kg)导致血清葡萄糖浓度显着降低,并表现出对镜片中山梨糖醇积累的抑制[2]。
参考文献

[1]. Jung HA, et al. Anti-adipogenic activity of the edible brown alga Ecklonia stolonifera and its constituent fucosterol in 3T3-L1 adipocytes. Arch Pharm Res. 2014 Jun;37(6):713-20.

[2]. Lee YS, et al. Anti-diabetic activities of fucosterol from Pelvetia siliquosa. Arch Pharm Res. 2004 Nov;27(11):1120-2.

[3]. Khanavi M, et al. Cytotoxicity of fucosterol containing fraction of marine algae against breast and colon carcinoma cell line. Pharmacogn Mag. 2012 Jan;8(29):60-4.

[4]. Caamal-Fuentes E, et al. Cytotoxic and antiproliferative constituents from Dictyota ciliolata, Padina sanctae-crucis and Turbinaria tricostata. Pharm Biol. 2014 Oct;52(10):1244-8.

密度 0.98 g/cm3
沸点 504.2ºC at 760 mmHg
熔点 118-120ºC
分子式 C29H48O
分子量 412.69100
闪点 220.3ºC
精确质量 412.37100
PSA 20.23000
LogP 7.94490
外观性状 白色粉末
蒸汽压 2.8E-12mmHg at 25°C
折射率 1.53
储存条件 2-8°C
分子结构

1、 摩尔折射率:128.91

2、 摩尔体积(m3/mol):416.8

3、 等张比容(90.2K):1036.9

4、 表面张力(dyne/cm):38.2

5、 极化率(10-24cm3):51.10

计算化学

1、 疏水参数计算参考值(XlogP):8.9

2、 氢键供体数量:1

3、 氢键受体数量:1

4、 可旋转化学键数量:5

5、 拓扑分子极性表面积(TPSA):20.2

6、 重原子数量:30

7、 表面电荷:0

8、 复杂度:687

9、 同位素原子数量:0

10、 确定原子立构中心数量:8

11、 不确定原子立构中心数量:0

12、 确定化学键立构中心数量:1

13、 不确定化学键立构中心数量:0

14、 共价键单元数量:1

更多

1. 性状:不确定

2. 密度(g/mL,25/4℃):不确定

3. 相对蒸汽密度(g/mL,空气=1):不确定

4. 熔点(ºC):118-120

5. 沸点(ºC,常压):不确定

6. 沸点(ºC, 5.2kPa):不确定

7. 折射率:不确定

8. 闪点(ºC):不确定

9. 比旋光度(º):D20 -38.4°(chloroform)

10. 自燃点或引燃温度(ºC):不确定

11. 蒸气压(kPa,25ºC):不确定

12. 饱和蒸气压(kPa,60ºC):不确定

13. 燃烧热(KJ/mol):不确定

14. 临界温度(ºC):不确定

15. 临界压力(KPa):不确定

16. 油水(辛醇/水)分配系数的对数值:不确定

17. 爆炸上限(%,V/V):不确定

18. 爆炸下限(%,V/V):不确定

19. 溶解性:溶于大多数有机溶剂


Section1. IDENTIFICATION OF THE SUBSTANCE/MIXTURE
Product identifiers
Product name: Fucosterol
CAS-No.: 17605-67-3
Relevant identified uses of the substance or mixture and uses advised against
Identified uses: Laboratory chemicals, Manufacture of substances



Section2. HAZARDS IDENTIFICATION
Classification of the substance or mixture
Not a hazardous substance or mixture according to Regulation (EC) No. 1272/2008.
This substance is not classified as dangerous according to Directive 67/548/EEC.
Label elements
The product does not need to be labelled in accordance with EC directives or respective national laws.
Other hazards - none

Section3. COMPOSITION/INFORMATION ON INGREDIENTS
Substances
: 5,24(28)-Stigmastadien-3β-ol
Synonyms
3β-Hydroxy-5,24(28)-stigmastadiene
Formula: C29H48O
Molecular Weight: 412,69 g/mol

Section4. FIRST AID MEASURES
Description of first aid measures
If inhaled
If breathed in, move person into fresh air. If not breathing, give artificial respiration.
In case of skin contact
Wash off with soap and plenty of water.
In case of eye contact
Flush eyes with water as a precaution.
If swallowed
Never give anything by mouth to an unconscious person. Rinse mouth with water.
Most important symptoms and effects, both acute and delayed
Some steroids show carcinogenic and teratogenic activity.
Indication of any immediate medical attention and special treatment needed
no data available

Section5. FIREFIGHTING MEASURES
Extinguishing media
Suitable extinguishing media
Use water spray, alcohol-resistant foam, dry chemical or carbon dioxide.
Special hazards arising from the substance or mixture
Carbon oxides
Advice for firefighters
Wear self contained breathing apparatus for fire fighting if necessary.
Further information
no data available

Section6. ACCIDENTAL RELEASE MEASURES
Personal precautions, protective equipment and emergency procedures
Avoid dust formation. Avoid breathing vapors, mist or gas.
Environmental precautions
Do not let product enter drains.
Methods and materials for containment and cleaning up
Sweep up and shovel. Keep in suitable, closed containers for disposal.
Reference to other sections
For disposal see section 13.

Section7. HANDLING AND STORAGE
Precautions for safe handling
Provide appropriate exhaust ventilation at places where dust is formed.Normal measures for preventive fire
protection.
Conditions for safe storage, including any incompatibilities
Store in cool place. Keep container tightly closed in a dry and well-ventilated place.
Recommended storage temperature: 2 - 8 °C
Specific end uses
no data available

Section8. EXPOSURE CONTROLS/PERSONAL PROTECTION
Control parameters
Components with workplace control parameters
Exposure controls
Appropriate engineering controls
General industrial hygiene practice.
Personal protective equipment
Eye/face protection
Use equipment for eye protection tested and approved under appropriate government standards
such as NIOSH (US) or EN 166(EU).
Skin protection
Handle with gloves. Gloves must be inspected prior to use. Use proper glove removal technique
(without touching glove's outer surface) to avoid skin contact with this product. Dispose of
contaminated gloves after use in accordance with applicable laws and good laboratory practices.
Wash and dry hands.
The selected protective gloves have to satisfy the specifications of EU Directive 89/686/EEC and
the standard EN 374 derived from it.
Body Protection
Choose body protection in relation to its type, to the concentration and amount of dangerous
substances, and to the specific work-place., The type of protective equipment must be selected
according to the concentration and amount of the dangerous substance at the specific workplace.
Respiratory protection
Respiratory protection is not required. Where protection from nuisance levels of dusts are desired,
use type N95 (US) or type P1 (EN 143) dust masks. Use respirators and components tested and
approved under appropriate government standards such as NIOSH (US) or CEN (EU).

Section9. PHYSICAL AND CHEMICAL PROPERTIES
Information on basic physical and chemical properties
a) AppearanceForm: solid
b) Odourno data available
c) Odour Thresholdno data available
d) pHno data available
e) Melting point/freezingno data available
point
f) Initial boiling point and no data available
boiling range
g) Flash pointno data available
h) Evaporation rateno data available
i) Flammability (solid, gas) no data available
j) Upper/lowerno data available
flammability or
explosive limits
k) Vapour pressureno data available
l) Vapour densityno data available
m) Relative densityno data available
n) Water solubilityno data available
o) Partition coefficient: n- no data available
octanol/water
p) Autoignitionno data available
temperature
q) Decompositionno data available
temperature
r) Viscosityno data available
s) Explosive propertiesno data available
t) Oxidizing propertiesno data available
Other safety information
no data available

Section10. STABILITY AND REACTIVITY
Reactivity
no data available
Chemical stability
no data available
Possibility of hazardous reactions
no data available
Conditions to avoid
no data available
Incompatible materials
Strong acids, Strong bases
Hazardous decomposition products
Other decomposition products - no data available

Section11. TOXICOLOGICAL INFORMATION
Information on toxicological effects
Acute toxicity
no data available
Skin corrosion/irritation
no data available
Serious eye damage/eye irritation
no data available
Respiratory or skin sensitization
no data available
Germ cell mutagenicity
no data available
Carcinogenicity
Some steroids show carcinogenic and teratogenic activity.
IARC:No component of this product present at levels greater than or equal to 0.1% is identified as
probable, possible or confirmed human carcinogen by IARC.
Reproductive toxicity
Some steroids show carcinogenic and teratogenic activity.
Specific target organ toxicity - single exposure
no data available
Specific target organ toxicity - repeated exposure
no data available
Aspiration hazard
no data available
Potential health effects
InhalationMay be harmful if inhaled. May cause respiratory tract irritation.
IngestionMay be harmful if swallowed.
SkinMay be harmful if absorbed through skin. May cause skin irritation.
EyesMay cause eye irritation.
Signs and Symptoms of Exposure
Some steroids show carcinogenic and teratogenic activity.
Additional Information
RTECS: Not available

Section12. ECOLOGICAL INFORMATION
Toxicity
no data available
Persistence and degradability
no data available
Bioaccumulative potential
no data available
Mobility in soil
no data available
Results of PBT and vPvB assessment
no data available
Other adverse effects
no data available

Section13. DISPOSAL CONSIDERATIONS
Waste treatment methods
Product
Offer surplus and non-recyclable solutions to a licensed disposal company.
Contaminated packaging
Dispose of as unused product.

Section14. TRANSPORT INFORMATION
UN number
ADR/RID: -IMDG: -IATA: -
UN proper shipping name
ADR/RID: Not dangerous goods
IMDG: Not dangerous goods
IATA:Not dangerous goods
Transport hazard class(es)
ADR/RID: -IMDG: -IATA: -
Packaging group
ADR/RID: -IMDG: -IATA: -
Environmental hazards
ADR/RID: noIMDG Marine pollutant: noIATA: no
Special precautions for user
no data available



SECTION 15 - REGULATORY INFORMATION
N/A


SECTION 16 - ADDITIONAL INFORMATION
N/A
个人防护装备 Eyeshields;Gloves;type N95 (US);type P1 (EN143) respirator filter
危险品运输编码 NONH for all modes of transport
WGK德国 3